News Release Details

Opiant Pharmaceuticals to Report Fourth Quarter 2021 Financial Results and Host Conference Call and Webcast on March 15, 2022

March 7, 2022 at 4:05 PM EST

SANTA MONICA, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report fourth quarter 2021 financial results and pipeline updates on Tuesday, March 15, 2022, after U.S. financial markets close.

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Tuesday, March 15, 2022. To access the call, please dial 1-877-407-0792 in the U.S., or 1-201-689-8263, outside the U.S. and provide the conference ID number: 13726931. To access the live webcast, please visit Following the live webcast, an archived version of the call will be available on the website.

Tuesday March 15 @ 4:30 pm ET
Domestic: 1-877-407-0792
International: 1-201-689-8263
Conference ID: 13726931

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: and follow Opiant on Twitter (@Opiant_Pharma).

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410

Primary Logo

Source: Opiant Pharmaceuticals, Inc.